Conference abstract · 29 Jul 2022
Conference abstractPublished 29 Jul 2022
Artificial intelligence (AI) in biomedical engineering
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Artificial intelligence (AI) refers to the simulation of human intelligence in machines that are programmed to think like humans and mimic their actions. Recent advances and applications of artificial intelligence (AI) in medicine via emphasizing this research area with novel biomaterials technology have shown great interest in medical applications. The way AI rapidly processes large amounts of information and arrives at likely causes for symptoms can drastically reduce the diagnosis-treatment-recovery cycle for many patients. The present seminar is divided into two parts; in the first part I will discuss the basic principle of the AI technology. In the second part, I will discuss the recent applications of AI technology in healthcare. I will further show some of our recent project in which AI technology has been used in biomedical engineering including in cancer, diabetes, biosensor, and tissue engineering. Historically, the term “artificial intelligence” dates to 1956 when it was first used in a conference at Dartmouth College in the US. Since then, the development of artificial intelligence has in part been shaped by the field of neuroscience. By understanding the human brain, scientists have attempted to build new intelligent machines capable of performing complex tasks akin to humans. Indeed, future research into artificial intelligence will continue to benefit from the study of the human brain. While the development of artificial intelligence algorithms has been fast paced, the actual use of most artificial intelligence (AI) algorithms in biomedical engineering and clinical practice is still markedly below its conceivably broader potentials. This is partly because for any algorithm to be incorporated into existing workflows it has to stand the test of scientific validation, clinical and personal utility, application context, and is equitable as well. In this context, there is much to be gained by combining AI and human intelligence (HI). Harnessing Big Data, computing power and storage capacities, and addressing societal issues emergent from algorithm applications, demand deploying HI in tandem with AI.
Keywords
- Artificial intelligence
- Biomedical Engineering
- Cancer
- Diabetes
- Biosensor
- and Tissue Engineering
- list of open access journals
- open access
- open access journals
- open access publication
- open access publisher
- open access publishing
- open access journal articles
- imedpub
- imedpub publishing
- insight medical publishing
- imedpub online
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 19 Nov 2021
Significance of Artificial Intelligence in ophthalmology: Review Article
Short communication · Sep 2020
Biomedical engineering and 3D printing
Other · 2 Jan 2020
EuroSciCon Conference on Biomedical Engineering
Other · 23 Dec 2019
EuroSciCon Conference on Biomedical Engineering Awards
More from this journal
The newest in Journal of Clinical Medicine and Therapeutics.
Commentary · 28 Feb 2025
Advances in Precision Medicine: Tailoring Treatments to Genetic Profiles
Opinion · 28 Feb 2025
Integrating Telemedicine into Chronic Disease Management
Short communication · 28 Feb 2025
Emerging Drug Therapies for Resistant Hypertension
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Medicine and Therapeutics
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Hossein Hosseinkhani”

